New mindfulness therapy targets PTSD in heart attack survivors
NCT ID NCT07410481
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new therapy called AMBET (Acceptance- and Mindfulness-Based Exposure Therapy) for treating PTSD in people who survived a cardiac arrest. About 90 adults will be randomly assigned to either AMBET or a standard talk therapy (PCT) for 12 weeks. Researchers will track PTSD symptoms, mood, sleep, and activity to see which therapy works better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may forecast brain recovery after cardiac arrest
- Faith-Based therapy aims to heal trauma in young women
- Could play be a lifeline for children of war? a major study investigates
- Can a High-Tech CPR bundle boost heart restart rates?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- Can a Phone-Based Self-Compassion program ease trauma for chinese immigrant women?